Atlas Trials

Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome

Clinical trial NCT00003984 · WITHDRAWN

Trial details

NCT number
NCT00003984
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
1999-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.